Senate Funding Bill Gives Cushion To FDA But Doesn't Undo Sequester-insidehealthpolicy: FDA would be able to collect previously authorized user fee amounts for prescription and generic drugs, medical devices and biosimilars and could receive a bump for some key programs, including food safety, under a Senate-proposed short-term spending bill unveiled this week. The FDA appropriations measure provides some flexibility for the agency, but does not do away with the cuts mandated by sequestration. The funding measure comes as House Republicans unveiled a budget plan that proposes deep cuts to non-defense discretionary programs like FDA.
Wednesday, March 13, 2013
Senate Funding Bill Gives Cushion To FDA But Doesn't Undo Sequester
Senate Funding Bill Gives Cushion To FDA But Doesn't Undo Sequester-insidehealthpolicy: FDA would be able to collect previously authorized user fee amounts for prescription and generic drugs, medical devices and biosimilars and could receive a bump for some key programs, including food safety, under a Senate-proposed short-term spending bill unveiled this week. The FDA appropriations measure provides some flexibility for the agency, but does not do away with the cuts mandated by sequestration. The funding measure comes as House Republicans unveiled a budget plan that proposes deep cuts to non-defense discretionary programs like FDA.
